chrisvoncsefalvay/vaers-outcomes huggingface dataset:
She started having head ticks, toe walking, lost 90 percent of her vocabulary, didnt like much touch. Started hours after her shot. She was about to graduate OT and ST and drastically regressed.  Nothing was helping and she kept getting worse. Finally started using TRS and she went back to her normal self after 3 days of heavy metal detox.
Patient received too many doses of vaccine. Patient has lost her cards in the past. Patient has the card from 01/25/2021 that is the first dose. Patient did not remember she got vaccinated on that day and received another "first" dose on 02/10/2021. Patient received a new card with that date. Patient then returned to the clinic on 03/10/2021 for her "Second" dose following the one given on 02/10/2021 and stated lost her card. Patient received a new card on that date. Patient came in today 12/13/2021 for her Booster vaccine. Patient had two separate cards, with the dates of 01/25/2021 on one and 02/10/2021 on the other card. Patient information was documented in all systems,
Information has been received from a 61 year old female patient referring to herself. The patient had allergies to bees and wasps. The patient had no medical history. On 18-JUN-2014 the patient was diagnosed with shingles and given the ZOSTAVAX (dose 1) the same day, which was other-than-indicated in the prescribing Information(off label use). The indication also reported as "prevent another outbreak of shingles". The patient later found out that her initial shot with ZOSTAVAX was expired by two months and that it had been administered(expired product administered) intramuscularly which was other-than-indicated in the prescribing Information(incorrect route of drug administration). The physician for this case did not perform the initial administration, it was administered by an unspecified nurse within the practice. The patient was told be re-vaccinated, and she complied with this direction. The revaccination occurred at a Pharmacy where she was administered another dose of ZOSTAVAX (dose 2) subcutaneously by an unspecified pharmacist on the same date (extra dose administered). No concomitant medication was reported. At that time(18-JUN-2014), she also was experiencing extreme arm pain to the point that she cannot lift her left arm after received the ZOSTAVAX vaccines. There was no treatment given to the events. X-ray was performed(result not provided). The patient sought medical attention by office visit. The outcome extreme arm pain and off label use was reported as not recovered/not resolved. Action taken and causality were not provided. No product quality issue(PQC) was involved. Additional information has been requested.
Fever developed 6 hours after immunization--Received ibuprofen/tylenol, rash developed about 15-18 hours after immunization and he was a bit more tired and clingy than normal.  rash looked similar to the post viral exanthum type of rash.
Pt recvd vax & exp serum sickness type react consisting of joint pain, weakness &/or diarrhea; workup has included numerous tests for collagen vascular disease, & been non-diagnostic;
Vaccine administration was above and posterior to the vastus lateralis, and therefore caused bruising and increased pain.
Mom phoned and stated that started 9/28/06 child had a fever. On 9/30/06, temp was 103 and child was jerking and twitching for 2 seconds 2 times. Rash was noted by mom started on child stomach then spread to face and neck then to her back and legs started 10/1/06 morning and the rash looked like chicken pox.
After the initial waiting period at the location I received the vaccine I walked around the store  a little while and then left and was walking up the street on the sidewalk. I caught my toe on a slightly lifted seam in the cement and instead of stumbling I did a complete uncontrollable fall forward landing on my face. I suffered a skinned forehead, two black eyes, a completely purple and a crushed nose and  skinned chin. I had no reflex reactions to catch myself or correct my footing at all.
Pt seen at ER - do not have records. Pt referred to Neurology clinic after ER visit.
Pt developed a progressingly enlarging local reaction, post vax, now 2 days. Size of area stabilized yesterday. There is itching. Treated with Benadryl.
The COVID-19 vaccine administered through vaccine administrator, University Health, between June 25 and July 30 came from the lot number 039K20A.  It was discovered that this particular lot was beyond its frozen expiration date by five (5) up to forty (40) days.  A case was opened with Moderna (Case #: MOD21-126790).  Please refer to this case number if you would like to contact Moderna directly.  Moderna confirmed that the vaccine doses administered maintained the activity necessary to protect against the COVID-19 virus.  Moderna also confirmed there is no danger to anyone's health from receiving a vaccine past its frozen expiration date.  No adverse reactions were identified.
(Janssen COVID-19 vaccine EUA) Day of vaccine - soreness in shoulder at the site of the injection.  Day 2 - continuing soreness of shoulder, along with general aches, chills, and sleepiness.  Day 3 - continuing soreness in shoulder, but no aches, chills, or sleepiness.  Began feeling nauseous, but still had appetite.  Day 4 - continuing soreness in shoulder, as well as nausea, but both are somewhat diminished.
Patient had swelling, redness, pain, and itching at site. Family took patient to the ER the day after vaccines and was diagnosed with cellulitis. Patient was placed on antibiotic treatment.
This spontaneous report was received from a nurse and refers to multiple unspecified patients of unknown age and gender. No information regarding the patients' pertinent medical history, concomitant medication and drug reactions or allergies was reported. On unknown dates, the patients were vaccinated with improperly stored doses of oral, ROTATEQ, lot # reported as L008059, expiration date 18-DEC-2016 (strength and dose were not provided). No adverse effects were reported. This is one of several reports received from the source. Additional information has been requested.
33 y/o female with past medical history of Anxiety, who presents with nervousness, fatigue and nausea post vaccination. Patient states that this is her 1st vaccination in the two-dose series. Patient denies previous reactions to vaccinations in the past. Patient denies headache, sore throat, difficulty breathing, chest pain, rash or itch. NP and Paramedics at patient side. Patient given water and placed to lay down on the cot. Patient was noted to be hypertensive (no known history), 173/106, 164/107, 173/110, 175/121, 174/188 BP and tachycardiac ranging between 114-138 HR. Patients O2 sats and Resp within normal limits. EKG was obtained and patient with noted Sinus Tach and occasional PVCs. Patient monitored for 30 minutes with no resolution of symptoms. At that time, it was determined by the NP to call Rescue. Rescue arrived on scene and monitored patient. Rescue advised that patient be transported to the ER due to symptoms but patient refusing. Patient states that she will go home and ask for a cardiology referral. Patient signed out AMA with Fire Rescue and with the NP (documentation provided and signed). Patient aware of risks associated with leaving AMA (Hypertensive Crisis, Stroke, cardiac event leading to death. Patient last set of vitals prior to AMA, 148/90 BP, 98% RA, 119 HR.
This case was reported by a pharmacist via call center representative and described the occurrence of rash in a adult patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received the 1st dose of SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced rash. On an unknown date, the outcome of the rash was unknown. It was unknown if the reporter considered the rash to be related to SHINGRIX. Additional details were reported as follows: The pharmacist called on behalf of the patient who was a physician. The age at vaccination was not reported. The age group was not reported but was captured adult as per vaccine indication. The reporting pharmacist did not provide any further details about the patient. The pharmacist stated that the patient would be able to provide further details upon contact. No further information was provided by the reporting pharmacist.
After patient received his vaccine, he became hot, diaphroretic, and flushed. He was wearing a long-sleeved shirt and jacket. We instructed him to take off his jacket and gave him a cool rag. After the 15 minutes of observation were up, he felt good. He denied any s/s of dizziness or light-headiness or shortness of breath. I called to check on him today and he reported that he feels a little tired and has some nausea at times. His arm is a little sore, but he is doing ok.
RESIDENT DIED WITHIN 30 DAYS OF ADMINISTRATION OF P-20 VACCINE
got the shot and still got shingles/suspected vaccination failure; got shingles; This case was reported by a consumer via media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were reported as follows: The case was reported by the patient. The age at vaccination was reported. The patient got the Shingles shot and still got shingles. The physician said it only work about 80 percent of the time. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory confirmation were unknown at the time of reporting.
Bleeding rectally for three days; couldn't think; Headache; Intestinal issues; Felt almost like she had COVID; Diarrhea; Nauseated; Felt like she was smothering; Felt foggy in her head like she couldn't think; Weak; Eye felt not right, blurry; Confused; This is a spontaneous report from a contactable consumer. A female patient of an unspecified age received bnt162b2 (BNT162B2), via an unspecified route of administration on an unspecified date (Batch/Lot Number: Not Provided) as 1ST DOSE, SINGLE for covid-19 immunization. The patient's medical history and  concomitant medications were not reported. The patient experienced bleeding rectally for three days, headache, intestinal issues, felt almost like she had covid, diarrhea, nauseated, felt like she was smothering, felt foggy in her head like she couldn't think, weak, didn't feel right, just not herself, eye felt not right, blurry and confused on an unspecified date. The outcome of bleeding rectally, headache, intestinal issues, felt almost like she had covid, diarrhea, nauseated, felt like she was smothering, felt foggy in her head like she couldn't think, weak, didn't feel right, just not herself, eye felt not right, blurry and confused  was unknown.  Information on the lot/batch number has been requested
Extreme fatigue, general malaise, all-over body aches, and complete lack of energy starting on the evening of the day of the shot and continuing for 12-18 hours. I just wanted to curl up in the fetal position and sleep.
My left nostril of the nose started bleeding; This is a spontaneous report from a contactable consumer (Patient). A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection), dose 1 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as DOSE 1, SINGLE for covid-19 immunization. Reportedly, received first dose of Pfizer vaccine at 6.30 pm. The patient medical history and concomitant medications were not reported. On an unspecified date patient had no complications and after finishing dinner was just sitting and left nostril of the nose started bleeding. It has stopped after some cold-water therapy.  Therapeutic measures were taken as a result of my left nostril of the nose started bleeding (epistaxis). Outcome of events was recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Mother described patient had hives on hands shortly after getting home. mother applied Benadryl cream on hives and resolved within a short time.
I became very itchy all over body Sunday, Oct 3. Over the course of that week I developed a rash, redness, hives all over body and experienced swelling of the face and throat. Went to the the hospital on Friday Oct 8. Was on oral steroids for a week and topical steroids for 2 weeks. Took allegra and benadryl during this time as well. Went to the allergist Oct 13. Blood work done Oct 13. Had patch testing done Nov 1, Nov 3, Nov 5. Experienced allergic reaction symptoms for about 3 weeks straight. Still get hives and contact dermatitis at random times to this day. Never had this before the vaccine.
Td & MMR given appox 1 min p/vax pt leaned to rt side & fell out of chair onto floor, pt was unresponsive for approx 3.5 seconds p/arousing pt was capable of answering questions; BP 118/50, pulse nl, coloring pale;
Pt developed violent vomiting 3 hrs after vaccination, followed by fever, going limp, pale and dusky with shallow respirations and apnea, requiring stimulation, O2.
Mentrual cycle occurred approximately 2 weeks early after my first shot and 1 week early after my second shot
Arm and vaccination site pain still 6 months later.  No treatments needed, but daily pain at injection site.
Sore Arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore Arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Feb-2021, the patient experienced PAIN IN EXTREMITY (Sore Arm). At the time of the report, PAIN IN EXTREMITY (Sore Arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment details included Cold Compress. relevant concomitant products usage were not reported by the reporter   Most recent FOLLOW-UP information incorporated above includes: On 28-Apr-2021: F/U received on 28-APR-2021,No New Information reported.
Staff member reported fever, chills and overall malice-symptoms subsided within 48 hours no treatment needed
temperature excursion for ROTATEQ; This spontaneous report as received from a physician refers to a patient of unknown age and gender. The patient's concurrent conditions, medical history and concomitant therapies were not reported.   On 30-APR-2021, the patient's were vaccinated with inappropriate stored dose of rotavirus vaccine, live, oral, pentavalent (ROTATEQ), orally lot# 1691299 and expiration date of 21-DEC-2021 (strength and dose were not provided) for prophylaxis. The temperature excursions were the following: Temperature (0.7°C) for 54 hours and 45 minutes; (8.6°C) for 47 hours 15 minutes. There was no previous temperature excursion. The call was registered due to a data logger. The adverse event report was filled precautionary.   This is one of several reports received from the same reporter
funny feeling or numbness (like novocaine) on the left side of his mouth; bad taste; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA ORAL (funny feeling or numbness (like novocaine) on the left side of his mouth) and TASTE DISORDER (bad taste) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.   On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced HYPOAESTHESIA ORAL (funny feeling or numbness (like novocaine) on the left side of his mouth) and TASTE DISORDER (bad taste). At the time of the report, HYPOAESTHESIA ORAL (funny feeling or numbness (like novocaine) on the left side of his mouth) and TASTE DISORDER (bad taste) outcome was unknown.            Action taken with mRNA-1273 in response to the events was not applicable  No concomitant medications was provided by the reporter.  No treatment medications was provided by the reporter.       Reporter did not allow further contact
1 st Vax- within 15min throat lymph nodes hurt/throat hurts, achy, sore sensation & achy chest, not fully chest pains but an ache upper chest. Blood pressure 99/70ish 98%O2  heart beats a bit high. Checked out by nurses at clinic  By 3:53pm left clinic in  stable condition. Symptoms didn't worsen. A bit of chest tightness and start of coughs. Took benadryl. It helped ease symptoms in about an hr.  4:20pm redness in face hands and chest. Tired feverish muscle aches. Eyes tired   By 5pm the chest discomfort disappeared.  By 1am April 16th the pain in throat had dimished, but a low ache and a sore sensation still persisted until 9am approx.
felt all side effect; Blister on the tongue and back of her mouth; felt like she was hit by a truck; throat swelling up; Red, hot, and hurt on arm; Throw Up Three Times; arm was swollen; Fever; Chills; Her head feels like it'll explode off her neck; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (felt like she was hit by a truck), ORAL MUCOSAL BLISTERING (Blister on the tongue and back of her mouth), VACCINATION COMPLICATION (felt all side effect), PHARYNGEAL SWELLING (throat swelling up) and INJECTION SITE WARMTH (Red, hot, and hurt on arm) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025L20A and 013m20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Allergy to venom (Bug bite.).   On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 07-Jan-2021, the patient experienced FEELING ABNORMAL (felt like she was hit by a truck), PHARYNGEAL SWELLING (throat swelling up), INJECTION SITE WARMTH (Red, hot, and hurt on arm), VOMITING (Throw Up Three Times), INJECTION SITE SWELLING (arm was swollen), PYREXIA (Fever), CHILLS (Chills) and HEADACHE (Her head feels like it'll explode off her neck). On 10-Jan-2021, the patient experienced ORAL MUCOSAL BLISTERING (Blister on the tongue and back of her mouth). On an unknown date, the patient experienced VACCINATION COMPLICATION (felt all side effect). On 09-Jan-2021, FEELING ABNORMAL (felt like she was hit by a truck), PHARYNGEAL SWELLING (throat swelling up), VOMITING (Throw Up Three Times), PYREXIA (Fever), CHILLS (Chills) and HEADACHE (Her head feels like it'll explode off her neck) had resolved. On 21-Jan-2021, INJECTION SITE WARMTH (Red, hot, and hurt on arm) and INJECTION SITE SWELLING (arm was swollen) had resolved. At the time of the report, ORAL MUCOSAL BLISTERING (Blister on the tongue and back of her mouth) and VACCINATION COMPLICATION (felt all side effect) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 07-Jan-2021, Body temperature: 102 (High) 102F. On 07-Jan-2021, Oxygen consumption decreased: 89 (Low) 89.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Treatment included for nausea medicine, Advil, Oxygen   Most recent FOLLOW-UP information incorporated above includes: On 09-Jun-2021: significant follow up On 09-Jun-2021: No new information; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
extremely irritable p/vax + erythema & induration @ inj site, t100.2 ACT-HIB site only;
Injection site scab; wound at injection site; This non-serious case was reported by a consumer via sales rep and described the occurrence of injection site scab in a 65-year-old female patient who received RSVPreF3 adjuvanted (Arexvy) for prophylaxis.   On 10-AUG-2023, the patient received the 1st dose of Arexvy (unknown arm). On an unknown date, an unknown time after receiving Arexvy, the patient experienced injection site scab (Verbatim: Injection site scab) and injection site injury (Verbatim: wound at injection site).  The outcome of the injection site scab was not resolved and the outcome of the injection site injury was not reported.   The reporter considered the injection site scab to be related to Arexvy. It was unknown if the reporter considered the injection site injury to be related to Arexvy.     The company considered the injection site scab to be related to Arexvy. It was unknown if the company considered the injection site injury to be related to Arexvy.   Additional Information: GSK receipt date: 2-Oct-2023 The pharmacist gave vaccination and the patient developed a wound at injection site. Referring health care professional phone number. The reporter consented to follow-up.
This spontaneous report was received from a healthcare professional refers to a unspecified number of unspecified patients of unknown age and gender. No medical history and concomitant medications were reported. On an unknown dates, the patients received improperly stored doses of PROQUAD (Lot# K023364, expiry: 20-MAY-2016). No adverse effect reported. This is one of several reports received from the same reporter. Additional information has been requested.
pt recv vax 3DEC97 & redness noted;4DEC97 no redness today 5DEC97;
Covid Pneumonia; tested positive for Covid; COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2), administration date 04Jan2022 (Batch/Lot number: unknown) as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Primary immunization completed, MANUFACTURER UNKNOWN), for COVID-19 Immunization. The following information was reported: COVID-19 PNEUMONIA (medically significant), outcome "unknown", described as "Covid Pneumonia"; DRUG INEFFECTIVE (medically significant), outcome "unknown", described as "tested positive for Covid"; COVID-19 (medically significant), outcome "unknown", described as "COVID-19". The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (24Jan2022) positive. The lot number for bnt162b2 was not provided and will be requested during follow up.
Mother states daughter received varivax in 1995.  Had chickenpox 2 weeks after brother but not as bad as brother.  Received Acyclovir 1 day earlier than brother.  Had 5 days fever - 104.5 f highest.
pt recv vax 1992 & pt devel a rash of small pinkish spots on back & shoulders;@ time of the report the third dose had not been administered;
This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. Relevant medical history and concomitant medication were not provided. On 13-FEB-2014 the patient was vaccinated with ZOSTAVAX lot # H019997. Dose, route and frequency were not provided. On 13-FEB-2014, an expired vaccine was administered. No adverse symptoms were reported. Additional information has been requested.